Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Elevated aldosterone levels in patients with androgenetic alopecia
British Journal of Dermatology, 06/15/09
Santiago SAA et al. - The elevated aldosterone values in these patients may contribute, together with other mechanisms, to the development of AGA and may also explain the higher prevalence of hypertension. Blood pressure screening of patients with AGA will permit earlier diagnosis of an unknown hypertension and initiation of appropriate treatment.
Salvador A. Arias Santiago, 06/16/09
| Androgenetic alopecia (AGA) has been related to an increase in cardiovascular risk by various authors, but the mechanism of this association has not been elucidated. There is reported to be an elevated prevalence of hypertension among AGA patients, and it has been proposed that both phenomena may be explained by the presence of hyperaldosteronism. Thus, high aldosterone levels underlie the majority of hypertension cases, and recent studies revealed the presence on mouse skin of mineralocorticoid receptors whose stimulation produces alopecia. However, no data on aldosterone levels in patients with androgenetic alopecia have been published to date.This study found significantly higher systolic BP values and aldosterone levels in alopecic men versus non-alopecic individuals. Aldosterone antagonists may exert a dual beneficial effect in hypertensive AGA patients, controlling BP and preventing alopecia progression, especially if taken in early stages. Hence, there is a need for new selective antagonists of aldosterone receptors to treat androgenetic alopecia in hypertensive patients without causing anti-androgenic side effects. |
Related Articles
Coudability hairs: a revisited sign of alopecia areata assessed by trichoscopy
Clinical and Experimental Dermatology, 11/16/09
Relevance Score: 84%
Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity or atopy
Clinical and Experimental Dermatology, 11/16/09
Relevance Score: 84%
Alefacept for Severe Alopecia Areata
Archives of Dermatology, 11/17/09
Relevance Score: 82%
Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia
Clinical and Experimental Dermatology, 11/17/09
Relevance Score: 82%
Attitudes of dermatologists in the southeastern United States regarding treatment of alopecia areata
BMC Dermatology, 11/13/09
Relevance Score: 82%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Improved 24-Hour Blood Pressure Control With Sirolimus Versus Calcineurin Inhibitor Based Immunosuppression in Renal Transplant Recipients
Transplantation Proceedings, 12/18/09
Zigzagged Augmentation Index in Diabetes
Clinical and Experimental Hypertension, 12/18/09
Scleroderma Renal Crisis: A Rare but Severe Complication of Systemic Sclerosis
Clinical Reviews in Allergy and Immunology, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


